Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study
Ana Pérez de José(Hospital General Universitario Gregorio Marañón), Marián Goicoechea(Hospital General Universitario Gregorio Marañón), Tamara Gelen Malek-Marín(Hospital de Sagunto), Javier Carbayo(Hospital General Universitario Gregorio Marañón), Natàlia Ramos Terrada(Vall d'Hebron Hospital Universitari), Loreto Fernández Lorente(Universidad de Navarra), Amir Shabaka(Hospital Universitario Fundación Alcorcón), Teresa Bada-Bosch(Hospital Universitario 12 De Octubre), Anna Pocurull(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Laura Martínez Valenzuela(Bellvitge University Hospital), Clara María Cases Corona(Hospital Universitario Fundación Alcorcón), Ana Huerta(Hospital Universitario Puerta de Hierro Majadahonda)
Cited by 19
Related Papers
COVID-19 in transplant recipients: The Spanish experience
|American Journal of Transplantation|2020|200
Use of tocilizumab in kidney transplant recipients with COVID-19
|American Journal of Transplantation|2020|85
Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
|Nephrology Dialysis Transplantation|2018|52
Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration
|Nutrients|2019|29
Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
|Journal of the American Society of Nephrology|2020|29